Lilly & REGN Failures Bad news for the world, but
Post# of 148165
Bad news for the world, but if one of these had been approved, it may have slowed or hindered or prevented a superior Leronlimab from being approved. We don't celebrate their failures, but we don't want another inferior drug like remdesivir to be approved and also slow Leronlimab's approval.